David Kardatzke
- Pulmonary and Respiratory Medicine top 0.2%
- Physiology top 1%
- Epidemiology top 5%
- Rheumatology top 2%
- Surgery top 10%
- Co-authors
- Williamson Z. BradfordMarilyn K. GlassbergPaul W. NobleLisa LancasterTalmadge E. KingSteven A. SahnIan GlaspoleSteven D. Nathan
- Topics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers)Pneumonia and Respiratory Infections (5 papers)Respiratory and Cough-Related Research (4 papers)
- Partner nations
- United StatesAustraliaBrazil
In The Last Decade
David Kardatzke
25 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Pulmonary and Respiratory Medicine 4.2k
- Physiology 1.4k
- Epidemiology 578
- Rheumatology 569
- Surgery 490
Countries citing papers authored by David Kardatzke
This map shows the geographic impact of David Kardatzke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kardatzke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kardatzke more than expected).
Fields of papers citing papers by David Kardatzke
This network shows the impact of papers produced by David Kardatzke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kardatzke. The network helps show where David Kardatzke may publish in the future.
Co-authorship network of co-authors of David Kardatzke
This figure shows the co-authorship network connecting the top 25 collaborators of David Kardatzke. A scholar is included among the top collaborators of David Kardatzke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Kardatzke. David Kardatzke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 51 | |
| 2 | 237 | |
| 3 | 30 | |
| 4 | 1 | |
| 5 | A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosisbreakdown → | 2606 |
| 6 | Effect of design modifications on trial outcomes in idiopathic pulmonary fibrosis (IPF): Analysis of data from ASCEND and CAPACITY (CAP) | 1 |
| 7 | Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsbreakdown → | 1478 |
| 8 | 1 | |
| 9 | 11 | |
| 10 | 98 | |
| 11 | 146 | |
| 12 | 50 | |
| 13 | Evaluation of individual subjects in the analog classroom setting: I. Examples of graphical and statistical procedures for within-subject ranking of responses to different delivery patterns of methylphenidate. | 29 |
| 14 | 135 | |
| 15 | 90 | |
| 16 | 8 | |
| 17 | 71 | |
| 18 | 10 | |
| 19 | 55 | |
| 20 | 17 |
About David Kardatzke
David Kardatzke is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Biological Psychiatry, having authored 25 papers that have together received 5.2k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Pneumonia and Respiratory Infections (5 papers) and Respiratory and Cough-Related Research (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.2k citations), Physiology (1.4k citations) and Rheumatology (569 citations). David Kardatzke has collaborated with scholars based in United States, Australia and Brazil. Frequent co-authors include Williamson Z. Bradford, Marilyn K. Glassberg, Paul W. Noble, Lisa Lancaster, Talmadge E. King, Steven A. Sahn, Ian Glaspole, Steven D. Nathan, Jeffrey J. Swigris and David J. Lederer. Their work appears in journals such as New England Journal of Medicine, The Lancet and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.